Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C16G2 Varnish for Dental Caries
NCT03004365Phase 2Completed
- Sponsor
- Armata Pharmaceuticals
- Start
- Jan 2017
- Primary completion
- Mar 2017
- Modality
- Antimicrobial Peptides, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of C16G2 in dental caries, sponsored by Armata Pharmaceuticals. Started Jan 2017; status: completed.
02
Drugs
C16G2
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT03004365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004365.